Skip to content
TrialScanner

NCT03392662

Hemopatch Performance Evaluation: A Prospective Observational Registry

No phase registeredCompletedBAXLead

Registry record

Lead sponsor
Baxter Healthcare Corporation
Conditions
Dura Mater Nick Cut or Tear; Hemostatis; Air Leakage; Body Fluid Leakage
Primary completion
Jan 28, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03392662 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03392662: Hemopatch Performance... | TrialScanner